BOZKOÇ VASİ, N. Et Al. 2023. Baseline Serum TSH Levels Predict The Thyroid Dysfunction In Cancer Patients Treated With Tyrosine Kinase Inhibitors And Immunotherapy. ECE 2023 .

BOZKOÇ VASİ, N., YORULMAZ, G., Bayır Gariboğlu, D., YILDIZ, B., & DİNCER, M., (2023). Baseline Serum TSH Levels Predict The Thyroid Dysfunction In Cancer Patients Treated With Tyrosine Kinase Inhibitors And Immunotherapy . ECE 2023

BOZKOÇ VASİ, NESLİHAN Et Al. "Baseline Serum TSH Levels Predict The Thyroid Dysfunction In Cancer Patients Treated With Tyrosine Kinase Inhibitors And Immunotherapy," ECE 2023, 2023

BOZKOÇ VASİ, NESLİHAN B. Et Al. "Baseline Serum TSH Levels Predict The Thyroid Dysfunction In Cancer Patients Treated With Tyrosine Kinase Inhibitors And Immunotherapy." ECE 2023 , 2023

BOZKOÇ VASİ, N. Et Al. (2023) . "Baseline Serum TSH Levels Predict The Thyroid Dysfunction In Cancer Patients Treated With Tyrosine Kinase Inhibitors And Immunotherapy." ECE 2023 .

@conferencepaper{conferencepaper, author={NESLİHAN BOZKOÇ VASİ Et Al. }, title={Baseline Serum TSH Levels Predict The Thyroid Dysfunction In Cancer Patients Treated With Tyrosine Kinase Inhibitors And Immunotherapy}, congress name={ECE 2023}, city={}, country={}, year={2023}}